(Q36555076)

14 August 2017

1 reference

title

Suppressant effects of conventional beta blockers and sotalol on complex and repetitive ventricular premature complexes (English)

1 reference

Cardiology and cardiovascular medicine

14 August 2017

main subject

1 reference

https://api.crossref.org/works/10.1016/0002-9149(90)90201-B

29 October 2022

author name string

P. C. Deedwania

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1688482

29 October 2022

language of work or name

English

0 references

publication date

1 January 1990

1 reference

14 August 2017

2 January 1990

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1688482

full work available at URL

29 October 2022

https://api.elsevier.com/content/article/PII:000291499090201B?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-9149(90)90201-B

https://api.elsevier.com/content/article/PII:000291499090201B?httpAccept=text/plain

29 October 2022

1 reference

https://api.crossref.org/works/10.1016/0002-9149(90)90201-B

American Journal of Cardiology

29 October 2022

published in

1 reference

14 August 2017

volume

65

1 reference

14 August 2017

issue

2

1 reference

14 August 2017

page(s)

43A-50A; discussion 51A-52A

1 reference

Reduction of sudden deaths after myocardial infarction by treatment with alprenolol. Preliminary results

14 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0002-9149(90)90201-B

Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction

29 October 2022

3

1 reference

https://api.crossref.org/works/10.1016/0002-9149(90)90201-B

Suppression of chronic ventricular arrhythmias with propranolol

29 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0002-9149(90)90201-B

Beta-adrenergic blockade by nadolol in control of ventricular tachyarrhythmias

29 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0002-9149(90)90201-B

Beta-blocking therapy in atrial and ventricular tachyarrhythmias: experience with nadolol

29 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0002-9149(90)90201-B

Treatment of premature ventricular complexes with acebutolol

29 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0002-9149(90)90201-B

Suppression of premature ventricular contractions by acebutolol

29 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0002-9149(90)90201-B

Pindolol for ventricular arrhythmia.

29 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0002-9149(90)90201-B

Accuracy of the ventricular tachycardia-induction study for predicting long-term efficacy and inefficacy of antiarrhythmic drugs

29 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0002-9149(90)90201-B

Exercise-triggered paroxysmal ventricular tachycardia. A repetitive rhythmic activity possibly related to afterdepolarization.

29 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0002-9149(90)90201-B

Exercise provocable right ventricular outflow tract tachycardia

29 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0002-9149(90)90201-B

Sotalol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use.

29 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0002-9149(90)90201-B

Multicenter trial of sotalol for suppression of frequent, complex ventricular arrhythmias: a double-blind, randomized, placebo-controlled evaluation of two doses.

29 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0002-9149(90)90201-B

Electrophysiologic and antiarrhythmic effects of sotalol in patients with life-threatening ventricular tachyarrhythmias

29 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0002-9149(90)90201-B

Beta-adrenergic receptor blocking drugs in cardiac arrhythmias

29 October 2022

18

1 reference

https://api.crossref.org/works/10.1016/0002-9149(90)90201-B

The Anti-Arrhvthmic Effects of Cardiac Denervation

29 October 2022

19

1 reference

https://api.crossref.org/works/10.1016/0002-9149(90)90201-B

Electrophysiologic effects of beta blockers in ventricular arrhythmias

29 October 2022

20

1 reference

https://api.crossref.org/works/10.1016/0002-9149(90)90201-B

Antihypertensive compounds as antiarrhythmic agents: focus on beta-blocking drugs in ventricular arrhythmias

29 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/0002-9149(90)90201-B

Beta-adrenoceptor blockade: electrophysiology and antiarrhythmic mechanisms

29 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/0002-9149(90)90201-B

Comparative effects of beta-adrenergic blocking drugs on experimental ventricular fibrillation threshold

29 October 2022

24

1 reference

https://api.crossref.org/works/10.1016/0002-9149(90)90201-B

Adaptation to prolonged beta-blockade of rabbit atrial, purkinje, and ventricular potentials, and of papillary muscle contraction. Time-course of development of and recovery from adaptation

29 October 2022

25

1 reference

https://api.crossref.org/works/10.1016/0002-9149(90)90201-B

Comparison of acebutolol with propranolol, quinidine, and placebo: results of three multicenter arrhythmia trials

29 October 2022

26

1 reference

https://api.crossref.org/works/10.1016/0002-9149(90)90201-B

Comparison of acebutolol and propranolol for treatment of chronic ventricular arrhythmia: a placebo-controlled, double-blind, randomized crossover study

29 October 2022

28

1 reference

https://api.crossref.org/works/10.1016/0002-9149(90)90201-B

Evaluation of metoprolol in suppressing complex ventricular arrhythmias

29 October 2022

29

1 reference

https://api.crossref.org/works/10.1016/0002-9149(90)90201-B

Antiarrhythmic effects of beta-adrenergic blocking agents in benign or potentially lethal ventricular arrhythmias

29 October 2022

30

1 reference

https://api.crossref.org/works/10.1016/0002-9149(90)90201-B

Beta blockers in combination with class I antiarrhythmic agents

29 October 2022

31

1 reference

https://api.crossref.org/works/10.1016/0002-9149(90)90201-B

The efficacy of sotalol in suppressing ventricular ectopic beats

29 October 2022

32

1 reference

https://api.crossref.org/works/10.1016/0002-9149(90)90201-B

Long-term sotalol therapy in patients with ventricular arrhythmias

29 October 2022

33

1 reference

https://api.crossref.org/works/10.1016/0002-9149(90)90201-B

Effects of the beta-adrenoceptor-blocking agent Sotalol on ventricular arrhythmias in patients with chronic ischemic heart disease. A placebo-controlled, double-blind cross-over study

29 October 2022

34

1 reference

https://api.crossref.org/works/10.1016/0002-9149(90)90201-B

Concentration-dependent pharmacologic properties of sotalol

29 October 2022

35

1 reference

https://api.crossref.org/works/10.1016/0002-9149(90)90201-B

Comparative efficacy of oral sotalol and procainamide in patients with chronic ventricular arrhythmias: a multicenter study

29 October 2022

36

1 reference

https://api.crossref.org/works/10.1016/0002-9149(90)90201-B

A comparison of the efficacy of sotalol and nadolol in the suppression of ventricular ectopic beats

29 October 2022

37

1 reference

https://api.crossref.org/works/10.1016/0002-9149(90)90201-B

Effects of sotalol on ventricular tachycardia and fibrillation produced by programmed electrical stimulation: comparison with other antiarrhythmic agents

29 October 2022

39

1 reference

https://api.crossref.org/works/10.1016/0002-9149(90)90201-B

When is QT prolongation antiarrhythmic and when is it proarrhythmic?

29 October 2022

40

1 reference

https://api.crossref.org/works/10.1016/0002-9149(90)90201-B

29 October 2022

Identifiers

1 reference

14 August 2017

1 reference